IBM Announces a 3-Year Contract Renewal for Bristol-Myers Squibb (BMY)
IBM (NYSE: IBM) announced a three-year contract renewal of mainframe and midrange hosting services for Bristol-Myers Squibb (NYSE: BMY). The agreement with IBM will allow Bristol-Myers Squibb to continue benefiting from applications running on System z mainframe and midrange systems as well as business recovery services for BMS's mission critical systems.
"We look forward to helping BMS continue to streamline these services through further consolidation and simplification," said Chris Nicoletti, IBM Vice President, Healthcare and Life Sciences Global Technology Services. "Assisting BMS with these services frees them to better serve their customers and support their strategic transformation to a biopharma leader."
Under the agreement, IBM will provide systems monitoring and management, back-up, disaster recovery, audit support, architectural guidance and project management for the continued use and streamlining of these systems.
International Business Machines Corporation (IBM) is an information technology (IT) company. [SM]
Related Categories
Corporate NewsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
